Advertising rules for regenerative medicine clinics

Advertise the clinic, not the cells.

Google bans stem cell and PRP promotion, and no certification unlocks it. What a regenerative clinic can advertise is everything else it does. Every rule below is quoted and dated.

Book a Call The full rulebook →

5.0 on Google, 11 reviews

PRPnamed outright in Google's ban on cell and gene therapy promotion
0stem cell or exosome products FDA has approved for any orthopedic condition
$5.1Mrefunds and civil penalties ordered against stem cell marketers sued by the FTC and Georgia, January 2025
  • 5.0 on Google, 11 reviews
  • Pelora Marketing does absolutely incredible work.Melissa B., Google review
  • $5M+ad spend managed
  • $15M+raised across his own companiesFounder Preston Durnford

For a regenerative clinic, a compliant ad sells the services Google never restricted, such as consults, diagnostics and physical medicine, and keeps stem cell, PRP and exosome therapy off the ad, the landing page and the booking menu behind it. Meta's policy does not name those therapies, but it bans cure claims for diseases like Parkinson's and ALS. FDA says no stem cell or exosome product is approved for orthopedic conditions.

A glowing cell stopped against a pane of glass that lights up orange where it touches
Why regenerative clinic ads get rejected

Five ways it goes wrong.

  • PRP by any name. Google names PRP in its ban, no certification unlocks it, and a branded PRP procedure is still PRP.
  • Knee pain. Stem cell, exosome, SVF, cord blood, Wharton's jelly and amniotic products alike: FDA says none of these products "have been approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain."
  • A disease list. The FTC's 2018 stem cell order bars claims that a product cures or treats Parkinson's, autism, multiple sclerosis and other conditions unless backed by competent and reliable scientific evidence.
  • A seminar funnel. In January 2025, court orders banned the Stem Cell Institute of America's founders from marketing stem cell therapy. The FTC said they trained clinics to recruit through ads and free "educational seminars."
  • Exosomes as a loophole. FDA: "There are currently no FDA-approved exosome products," and "as a general matter" exosomes used to treat diseases and conditions in humans are regulated as drugs and biological products.
The rules, with dates

What Google, Meta, FDA and the FTC say.

Each card quotes its source's own page, read on 26 September 2026.

NamedGoogle does not allow promotion of "Stem cell therapy," "Cellular (non-stem) therapy" or "Platelet rich plasma, also referred to as PRP therapies."Google Ads, Speculative and experimental medical treatment
7 daysGoogle: "A warning will be issued at least 7 days prior to any suspension of your account." Its US exception is for FDA-licensed therapies, promoted by the license holder.Google Ads, Speculative and experimental medical treatment
CuresMeta bans claims, "including those from health professionals," to cure, heal or eliminate Parkinson's, Alzheimer's, ALS, diabetes and the other diseases on its list.Meta Health and Wellness policy, change log Jul 22, 2026
ApprovedFDA: the only approved stem cell products are blood-forming cells from umbilical cord blood, for blood disorders, and "they are not approved for other uses."FDA consumer alert, current as of 04/09/2024

Where each ad can run

Read at the source, 26 September 2026
Your ad sells consults, diagnostics or physical medicine
Your ad sells stem cells, PRP or exosomes
Google Search
Can run

No certification needed. Google judges keywords one at a time.

Not allowed

No certification unlocks it. Google exempts only ads that are exclusively educational or informational, such as academic papers or medical conference tickets.

Google Display and DV360
Can run

The same rules as Search, Display & Video 360 included.

Not allowed

The same ban, and the same educational exception.

Meta
Can run, 18+

18-plus as a health service, with no cure claims.

Not named

Not named in Meta's policy, and silence is not permission.

FDA
Describe it

Describe the service as it is.

Not approved

No approved stem cell or exosome product for orthopedic, neurological or heart conditions; cord blood cells for blood disorders are the approved exception.

FTC
Evidence first

Claims need competent and reliable scientific evidence.

Court orders

Court orders, refunds and a marketing ban in FTC stem cell cases since 2018.

Platform, FDA and FTC lines read on each source's own page on 26 September 2026. Exosomes and plasma exchange are not named on Google's page; we treat them as covered by its "similar forms of regenerative medicine," which is our reading.

Not sure which of your services can run? We read the ad, the page and the booking menu before anything spends.

Book a Call
Google is not Meta

Four surfaces, one verdict.

Each card says whether it is policy text or what we have seen in live clinic accounts.

KeywordsGoogle judged health keywords one string at a time in two unrelated clinic accounts: in one ad group it flagged 2 keywords and passed the rest.PELORA Research Study 01, September 23, 2026
DestinationGoogle's healthcare policies expect "ads and destinations" to follow the law and industry standards, so the landing page is read too.Google Ads, Speculative and experimental medical treatment
Booking menuOur practice, not Google's words: the booking tool one click away counts as the destination too, so regenerative services stay off it.PELORA practice, stated as ours
Programmatic"Display & Video 360 users must comply with this Google Ads policy." A buy through Google's own DSP does not route around the ban; other platforms have their own rules.Google Ads, Speculative and experimental medical treatment

How we find the line before spending real budget

In our published study the verdict could not be predicted from the policy text, so we submit a small test set first, from clearly safe to clearly restricted, and never promise a launch date before Google answers.

The policy's exception request is for FDA-licensed products, made by the entity that holds the license, alongside an ordinary appeal. We read it as written for manufacturers rather than clinics, and that is our reading.

Same clinic, two ads

Relief, described honestly.

On Meta, no copy may assume something about the viewer's body or health. The good line also names no regenerative product and promises no result, which is what FDA's letters and the FTC's orders turned on.

Both ads are illustrations, not a client's account.

PELORA example ad · Sponsored
“Still living with knee pain?”
Assumes
It assumes something about the viewer's body.
PELORA example ad · Sponsored
“Physician consults for joint and sports injuries”
Describes
No regenerative product named, no result promised.
What we do differently

Every regenerative post, read by a person.

Two rounds, by a person, before anything runs: every ad and the page one click away, read against Google, Meta, FDA and the FTC. Anything naming a prescription drug gets a drug-ad review, which is why a creator program for prescription products adds $1,000 a month.

  • ClaimsNo heal, regenerate, repair, cure or "alternative to surgery."
  • EvidenceAny outcome number shown with the study behind it.
  • The pageOrganic pages can explain regenerative care; the ad's destination does not sell it.
Two glass lenses focused on one glowing cell, a first and a second read
Map of the United States with Newport Beach, California marked
Where we work

Newport Beach office. Clients anywhere.

Platform rules are national, FDA and FTC rules are federal, and state medical boards add their own, so we check licensed states against geo-targeting first.

CaliforniaFloridaTexasArizonaNevadaColoradoNew YorkAnywhere in the US
Related

Go deeper.

Regenerative marketingThe full system for regenerative medicine clinicsCreators for regenerativeWho they are, where it runs, what they can sayThe full rulebookMeta, Google, LegitScript, FDA, with dates
Questions

Asked by regenerative clinics.

Can a regenerative medicine clinic run programmatic or display ads?
Not through Google Ads or Display & Video 360 for stem cell, PRP or exosome therapy: Google's speculative treatment policy says Display & Video 360 users must comply with it, and it names stem cell therapy and PRP. Other programmatic platforms set their own health rules, which we read before buying. The clinic's other services can run on the same channels.
Can a stem cell clinic advertise?
Not the stem cell therapy on Google, and not with orthopedic or disease claims anywhere. Google bars promoting stem cell therapy except FDA-licensed products promoted by the license holder. FDA says no stem cell product is approved for orthopedic conditions, and the FTC has ordered stem cell marketers to pay refunds and penalties.
Can we advertise PRP on Google?
No. Google names "Platelet rich plasma, also referred to as PRP therapies" among cell and gene therapies it does not allow, and no certification unlocks it. A violation brings a warning at least 7 days before any suspension.
What about Meta ads for PRP or stem cells?
Meta's policy does not name PRP, stem cells or exosomes, which is not permission. It bans claims, including from health professionals, to cure the diseases on its list, such as Parkinson's and ALS. We build Meta ads around the clinic's other services.
Can we buy stem cell leads from a lead generation company?
The rules follow the ad, whoever runs it: a vendor's ad for your stem cell service is still stem cell promotion on Google. In 2025, court orders in a case brought by the FTC and Georgia banned the co-founders and companies behind a program that trained clinics to market stem cell therapy through ads and seminars.
Do we need LegitScript for a regenerative clinic?
Almost certainly not. LegitScript is Google's route for telemedicine and online pharmacies, and it does not unlock stem cell or PRP, which sit under a prohibition rather than a restriction.
Do you work with regenerative clinics outside California?
Yes, across the United States from Newport Beach. We check licensed states against geo-targeting first, because Google's unauthorized pharmacies policy, for businesses that offer prescription drugs, suspends an account without warning for targeting a location where it is not licensed.

Sources, all read on September 26, 2026: Google Ads, Speculative and experimental medical treatment, cell therapies, and gene therapies, Healthcare and medicines and Unauthorized pharmacies; Meta Transparency Center, Health and Wellness (change log Jul 22, 2026); FDA Consumer Alert on Regenerative Medicine Products (current as of April 9, 2024) and Public Safety Notification on Exosome Products; FTC releases of October 18, 2018 and January 8, 2025; PELORA Research Study 01 (September 23, 2026).

Before the next campaign

Get the account read first.

Fifteen minutes. Bring your service list and the ad that got rejected. We will tell you which services can run, where, and what stays organic.

Book a Call Creators for regenerative clinics →

5.0 on Google, 11 reviews